Factors associated with resistance to SARS-CoV-2 infection discovered using large-scale medical record data and machine learning.
There have been over 621 million cases of COVID-19 worldwide with over 6.5 million deaths. Despite the high secondary attack rate of COVID-19 in shared households, some exposed individuals do not contract the virus. In addition, little is known about whether the occurrence of COVID-19 resistance differs among people by health characteristics as stored in the electronic health records (EHR). In this retrospective analysis, we develop a statistical model to predict COVID-19 resistance in 8,536 individuals with prior COVID-19 exposure using demographics, diagnostic codes, outpatient medication orders, and count of Elixhauser comorbidities in EHR data from the COVID-19 Precision Medicine Platform Registry. Cluster analyses identified 5 patterns of diagnostic codes that distinguished resistant from non-resistant patients in our study population. In addition, our models showed modest performance in predicting COVID-19 resistance (best performing model AUROC = 0.61). Monte Carlo simulations conducted indicated that the AUROC results are statistically significant (p < 0.001) for the testing set. We hope to validate the features found to be associated with resistance/non-resistance through more advanced association studies..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:18 |
---|---|
Enthalten in: |
PLoS ONE - 18(2023), 2, p e0278466 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Kai-Wen K Yang [VerfasserIn] |
---|
Links: |
doi.org [kostenfrei] |
---|
Themen: |
---|
doi: |
10.1371/journal.pone.0278466 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
DOAJ079840892 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ079840892 | ||
003 | DE-627 | ||
005 | 20230410123131.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230310s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1371/journal.pone.0278466 |2 doi | |
035 | |a (DE-627)DOAJ079840892 | ||
035 | |a (DE-599)DOAJ7f149fbff4f04fb481d548a1b6dc7c0d | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 0 | |a Kai-Wen K Yang |e verfasserin |4 aut | |
245 | 1 | 0 | |a Factors associated with resistance to SARS-CoV-2 infection discovered using large-scale medical record data and machine learning. |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a There have been over 621 million cases of COVID-19 worldwide with over 6.5 million deaths. Despite the high secondary attack rate of COVID-19 in shared households, some exposed individuals do not contract the virus. In addition, little is known about whether the occurrence of COVID-19 resistance differs among people by health characteristics as stored in the electronic health records (EHR). In this retrospective analysis, we develop a statistical model to predict COVID-19 resistance in 8,536 individuals with prior COVID-19 exposure using demographics, diagnostic codes, outpatient medication orders, and count of Elixhauser comorbidities in EHR data from the COVID-19 Precision Medicine Platform Registry. Cluster analyses identified 5 patterns of diagnostic codes that distinguished resistant from non-resistant patients in our study population. In addition, our models showed modest performance in predicting COVID-19 resistance (best performing model AUROC = 0.61). Monte Carlo simulations conducted indicated that the AUROC results are statistically significant (p < 0.001) for the testing set. We hope to validate the features found to be associated with resistance/non-resistance through more advanced association studies. | ||
653 | 0 | |a Medicine | |
653 | 0 | |a R | |
653 | 0 | |a Science | |
653 | 0 | |a Q | |
700 | 0 | |a Chloé F Paris |e verfasserin |4 aut | |
700 | 0 | |a Kevin T Gorman |e verfasserin |4 aut | |
700 | 0 | |a Ilia Rattsev |e verfasserin |4 aut | |
700 | 0 | |a Rebecca H Yoo |e verfasserin |4 aut | |
700 | 0 | |a Yijia Chen |e verfasserin |4 aut | |
700 | 0 | |a Jacob M Desman |e verfasserin |4 aut | |
700 | 0 | |a Tony Y Wei |e verfasserin |4 aut | |
700 | 0 | |a Joseph L Greenstein |e verfasserin |4 aut | |
700 | 0 | |a Casey Overby Taylor |e verfasserin |4 aut | |
700 | 0 | |a Stuart C Ray |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t PLoS ONE |d Public Library of Science (PLoS), 2007 |g 18(2023), 2, p e0278466 |w (DE-627)DOAJ000113018 |x 19326203 |7 nnns |
773 | 1 | 8 | |g volume:18 |g year:2023 |g number:2, p e0278466 |
856 | 4 | 0 | |u https://doi.org/10.1371/journal.pone.0278466 |z kostenfrei |
856 | 4 | 0 | |u https://doaj.org/article/7f149fbff4f04fb481d548a1b6dc7c0d |z kostenfrei |
856 | 4 | 0 | |u https://doi.org/10.1371/journal.pone.0278466 |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/1932-6203 |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_DOAJ | ||
951 | |a AR | ||
952 | |d 18 |j 2023 |e 2, p e0278466 |